230 likes | 934 Views
Objective. Review presentation and differential diagnosis of eosinophilia. Case Patient History. 65 yo white female presents to ED with intermittent upper abd/epigastric pain over previous 2 weeks that has not responded to PPI/H2 blocker, bland diet4-8/10 pain, mild nausea and anorexia, yellowish green stool, no blood in stool, mildly constipated, gassiness present, no diarrhea, 3 pound wt loss in one weekUS done earlier in the day was normal.
E N D
1. Clinical Case Presentation: A Case of Eosinophilia Kristin Steffen, MD
GIM Conference
02/13/08
2. Objective Review presentation and differential diagnosis of eosinophilia
3. Case Patient History 65 yo white female presents to ED with intermittent upper abd/epigastric pain over previous 2 weeks that has not responded to PPI/H2 blocker, bland diet
4-8/10 pain, mild nausea and anorexia, yellowish green stool, no blood in stool, mildly constipated, gassiness present, no diarrhea, 3 pound wt loss in one week
US done earlier in the day was normal
4. Case Patient Past Medical History Asthma for 25 years
HTN
MHA
Pericarditis 3/07
Pulmonary nodules found on CT 3/07, unchanged but new nodules per improved CT technique 6/07, new subpleural nodule, increased soft tissue at pericardial margin, ? Inflammatory 9/07
Cataract surgery:OS 9/17, OD 10/1/07
5. Case Patient Medications Advair
Albuterol
Singulair
Astelin nasal
Rhinocort
Guaifenesin LA Premarin Vag cream
Lisinopril
Fish oil
Simvastatin
Centrum mvit
Imitrex
6. Case Patient Social and Family History Retired med tech/ administrator for State Lab of Hygiene
Lives with husband rural SW Wisconsin
Camped in Canada near Lake Superior 9/07, drank well water
EtOH: 1 wine/d, nonsmoker, no illicit drugs
7. Case Patient Admit Exam T 37, P78, R 12, 95% RA BP 138/82
Gen: NAD
HEENT: post-op cataract surgery changes
Abdomen: unremarkable at time of exam
Lungs, Heart, Neuro, Skin, Extremities: WNL
8. Case Patient Admit Labs WBC 23.4: 13,080 E, 7,740 N, 1470 L, 1060 M, 50 B
Ca 9.8, t prot 7.9, alb 4.0
Troponin 0
Lipase 193
ESR 36
T bili 0.5
Alk phos 218 (35-130)
AST 27, ALT 49
GGT 117
CT Abd: no new findings (unchanged pulm nodules, adrenal adenoma)
9. DDx Eosinophilia Infectious Disease
Helminthic parasitic
Fungal (ABPA, Cocci)
Scabies, myiasis
Allergic
Drug hypersensitivity
Atopic diseases
Immunologic
Primary immune defic (Hyper IgE, Omenn syndrome)
Graft vs host disease
Malignancy
Leukemia, lymphoma
AdenoCA, SCCA, Large cell lung, transitional cell bladder
Systemic mastocytosis
Other
Hypoadrenalism
Irradiation
Atheroembolsim
Sarcoidosis
10. DDX Eosinophilia, cont. Hypereosinophilia syndrome (HES)
Myeloproliferative variant (fusion protein)
Lymphocytic variant (clonal lymphocytes)
Familial
Undefined (Benign, Complex, Episodic)
Overlap (ie eos gi diseases, eos pneumonia, eos myalgia)
HES Associated Disorders (see next slide)
11. DDX Eosinophilia, cont. HES-Associated Disorders
Churg-Strauss syndrome
Systemic mastocytosis
Sarcoidosis
HIV
Inflammatory bowel disease
12. Definition of HES Periph blood eosinophilia with abs eos>1500 for more than 6 months
No other evident causes for eosinophilia, including allergic disease and parasitic infection
Signs or symptoms of organ involvement by eosinophilic infiltration
13. HES Organ Involvement Cardiovascular (58%)
Cutaneous (54%)
Neurologic (54%): Encephalopathy/UMN signs, polyneuropathy, mononeuritis multiplex, radiculopathies and related muscle atrophy
Splenic (53%)
Pulmonary (49%): chronic non-productive cough, NOT wheezing, diffuse and focal infiltrates, pleural effusion
14. HES Organ Involvement, cont. GI (23%): esophagitis, gastroenteritis, colitis
Ocular (23%)
15. More on Churg-Strauss Syndrome Small-vessel necrotizing vasculitis with asthma (100%), lung infiltrates (38-77%), extravascular necrotizing granulomas and hypereosinophilia
Allergic rhinitis/sinus polyps (70%)
Peripheral neuropathy (50-78%)
Cardiac (60%)
GI (37-62%)
Kidney (16-49%)
Skin (40-75%)
16. Treatment HES
Prednisone
Interferon alpha, hydroxycarbamide
Cytotoxic agents
Cyclosporine
Imatinib (1/3 of idiopathic/nonmyeloproliferative cases respond
Monoclonal antibody therapy
Myeloablative and nonmyeloablative allograft under study
17. Treatment Churg-Strauss
Prednisone +/- preceding methylpred pulse dose
Cyclophosphamide /azathioprine
Monoclonal Ab (several types)
Interferon alpha
18. Case Patient: Further Diagnostics Flow cytometry normal
Bone marrow biopsy normal
BM AFB negative
IgE 78 (0-180)
C-ANCA, P-ANCA negative
Histo, Blasto, AB negative
Giardia Ag negative
Galactomannan normal
Tryptase normal
HIV negative
19. Case Patient: Clinical Course Toe paresthesia 3 days later-EMG neg
Prednisone 60 mg daily, eos count nl within 10 days
Zoster in trigeminal distribution with eye involved
Transient global amnesia 3 weeks later-viral encephalitis ruled out by neuro work up
Cardiac Echo normal
Sural nerve biopsy pending (“highly informative” in Churg-Strauss)
20. Case Patient Diagnosis Hypereosinophilia syndrome versus Churg-Strauss syndrome, favor Churg-Strauss
21. References Sheikh J, Weller PF. Clinical overview of hypereosinophilic syndromes. Immunol Allergy Clin N Am 2007;27: 333-355.
Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol 2007;19(1):25-32.
Fletcher S, Bain B. Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol 2007;14:37-42.
Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin N Am 2007;27:529-549.